Business Wire

ROYC, Elvinger Hoss, and GDA: Strategic Fund Architecture – Capturing the Next Wave of Private Capital

Share

ROYC, together with leading law firms Elvinger Hoss and GDA, today announced the publication of a joint white paper, Strategic Fund Architecture – Capturing the Next Wave of Private Capital. The report offers General Partners (GPs) and asset managers a practical roadmap to navigate Europe’s rapidly evolving fund structuring and distribution landscape.

With ELTIF 2.0 now in force, AIFMD II implementation approaching, and the EU’s Savings & Investments Union (SIU) expected to channel trillions of euros of household savings into long-term private markets, fund structuring has become a board-level strategic priority.

“Fund structuring is no longer just a back-office concern. Operational platforms and technology are now decisive in determining capital access, speed-to-market, and GP profitability,” said Mathias Leijon, Founder & President at ROYC. “This paper shows how integrating legal, operational, and technology architecture from day one transforms fund formation and lifecycle management into distinct competitive advantages.”

Key market forces shaping the next vintage cycle (2026–27):

  • Broadened LP base – from sovereign wealth funds to first-time HNWIs, requiring digital onboarding, transparent reporting, and harmonized data.
  • Regulatory reform – ELTIF 2.0 and SIU create new channels to mass-affluent and retail markets, demanding compliant and scalable structures.
  • Technology-driven scale – modular, cloud-native platforms lower cost-to-serve, accelerate time-to-market, and enable semi-liquid and evergreen funds alongside closed-end funds and co-investment vehicles.

For GPs, the next vintage cycle (2026–27) will set new benchmarks in fund design, governance, and investor experience. Firms that act now—embedding integrated operating platforms alongside best-in-class structuring—will secure lasting advantages in capital access and cost of capital.

The white paper provides actionable guidance across five dimensions: strategic scoping, wrapper selection, regulatory timelines, platform-driven operating models, and distribution activation. It also outlines use cases ranging from first-time managers seeking institutional-grade platforms to global GPs building cross-border strategies.

ABOUT ROYC

ROYC is the leading European B2B financial technology company that provides a complete private markets operating system, empowering private equity firms, banks, wealth managers, and multi-family offices to seamlessly access, distribute, and manage private investments at scale. As private markets expand, financial institutions require scalable, technology-driven solutions to manage complexity, optimizing fund operations, and delivering exceptional client experiences. ROYC combines state-of-the-art private markets technology with tailored fund structuring and investment solutions. Its intuitive, scalable platform replaces manual processes with automation and real-time data access, transforming how private market investments are managed across the entire fund lifecycle.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250909149085/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LambdaTest Launches AI-Native Smart Heal to Enhance Reliability of Automation Testing10.9.2025 17:00:00 CEST | Press release

New self-healing capability minimizes brittle tests and improves CI/CD stability LambdaTest, a GenAI-powered quality engineering platform, today announced the release of AI-Native Smart Heal for Automation Testing, a breakthrough capability designed to overcome one of the most persistent challenges in application testing: locator failures. Locator failures often lead to broken and flaky automation scripts, resulting in frequent test breaks, increased maintenance costs, and delays in development cycles. With Smart Heal, LambdaTest introduces an AI/ML-powered mechanism that automatically detects and recovers from locator issues during test execution. This ensures smoother, more resilient automation runs even as user interfaces evolve. Smart Heal captures a baseline of successful test executions and uses AI analysis to detect UI changes. When an element cannot be located due to DOM or UI modifications, the system identifies the closest valid match and retries the step to keep execution un

World’s Largest Dental Research Meeting to Be Held in Yokohama in 202910.9.2025 17:00:00 CEST | Press release

The 2029 International Association for Dental, Oral, and Craniofacial Research (IADR) General Session & Exhibition will be held in Yokohama from June 27 to June 30, 2029, marking the return of the event to Japan after 28 years. The IADR General Session is held in conjunction with the IADR Asia Pacific Regional (APR) Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910478673/en/ YOKOHAMA JAPAN'S FIRST PORT OF CALL Working in partnership with the City of Yokohama and the Japan National Tourism Organization (JNTO), the Yokohama City Visitors Bureau (YCVB) and PACIFICO Yokohama have secured the bid to host the 2029 IADR General Session—owing to Yokohama’s convenient access, excellent reputation in hosting international conferences, and robust support infrastructure. The decision was also based on the extensive legacy of world-leading dental, oral, and craniofacial research in Japan, and the long-standing activities of

INNORNA Completes Phase II Enrollment and Vaccination of Bivalent RSV mRNA Vaccine IN00610.9.2025 15:21:00 CEST | Press release

Innorna today announced the completion of enrollment and vaccination in its Phase II clinical trial for IN006, the world’s first bivalent respiratory syncytial virus (RSV) mRNA vaccine currently in development by the company. IN006 is also China's first domestically developed RSV vaccine to enter clinical trials, following IND approval in June 2024. The Phase I trial began with the first subject vaccinated in November 2024. Completion of enrollment and dosing in Phase II marks a milestone toward dose optimization and sets the stage for Phase III efficacy studies. The Phase II study is a randomized, double-blind, placebo-controlled trial conducted in China among healthy adults aged 60 and above. Key study objectives include dose optimization, broader population validation, and booster evaluation for annual revaccination. “This Phase II clinical trial marks a critical step in validating IN006’s scientific hypothesis—delivering broad-spectrum, durable protection against RSV,” said Dr. Lin

Xsolla Web Shop and Singular Join Forces to Deliver Cross-Platform LTV and ROAS Measurement Solutions10.9.2025 15:00:00 CEST | Press release

Xsolla Web Shop and Singular S2S Integration Bridges the Gap Between Mobile Marketing and Web Transactions for Complete Campaign Visibility Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announced a new mobile-focused Server-to-Server (S2S) integration with Singular, a leading marketing analytics and attribution platform. The integration unifies mobile marketing data with direct-to-consumer web purchases, enabling developers to measure campaign performance and player value more accurately than ever before. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910813948/en/ Graphic: Xsolla As mobile game makers increasingly turn to Web Shops to expand revenue streams beyond app stores, one challenge has persisted: how to tie those off-platform transactions back to mobile marketing spend. The Xsolla Web Shop + Singular S2S integration closes this gap by treating Web

Veritas Capital Closes Ninth Flagship Fund at Hard Cap of $14.4 Billion10.9.2025 15:00:00 CEST | Press release

Fundraise represents a 35% increase over Fund VIII and brings Veritas’s AUM to more than $54 billionContinues Firm’s mission of transforming technology and government-aligned businesses Veritas Capital (“Veritas”), a leading investor at the intersection of technology and government, today announced the final close of The Veritas Capital Fund IX (“Fund IX”) with $14.4 billion in aggregate capital commitments. Fund IX was significantly oversubscribed, with demand exceeding the hard cap and surpassing the initial target of $13 billion. The fundraise represents a 35% increase over Fund VIII which closed at $10.7 billion in 2022. With the close of Fund IX, Veritas now manages more than $54 billion in assets across its strategies, strengthening its position as a leading investor focused on technology. “Fund IX represents an important step forward for Veritas, and I’m deeply proud of our team and the enduring partnerships that made this milestone possible,” said Ramzi Musallam, Chief Executiv

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye